Down syndrome and leukemia: unusual clinical aspects and unexpected methotrexate sensitivity.
about
Identification of AML1-ETO modulators by chemical genomicsImproved outcome of acute myeloid leukaemia in Down's syndrome.Molecular and cellular correlates of methotrexate response in childhood acute lymphoblastic leukemia.Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia.Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathologyPrognosis of Down's syndrome with acute leukaemia.Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritisMyelosuppression and infectious complications in children with Down syndrome and acute lymphoblastic leukemia.Down syndrome and acute lymphoblastic leukaemia.Pharmacokinetics of Chemotherapeutic Drugs in Pediatric Patients With Down Syndrome and Leukemia.Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome.Malignancy in children with trisomy 21.Unique clinical and biological features of leukemia in Down syndrome children.Methotrexate pharmacology and resistance in childhood acute lymphoblastic leukemia.Acute leukemia in children with Down syndrome.Acute myelogenous leukaemia in children under 2 years--experiences of the West German AML studies BFM-78, -83 and -87. AML-BFM Study Group.Pharmacokinetics of acyclovir in immunocompromized children with leukopenia and mucositis after chemotherapy: can intravenous acyclovir be substituted by oral valacyclovir?Altered clearance of theophylline in children with Down syndrome: a case series.Pulmonary hemosiderosis in children with Down syndrome: a national experience.Myelopathy mimicking subacute combined degeneration in a Down syndrome patient with methotrexate treatment for B lymphoblastic leukemia: report of an autopsy case.
P2860
Q24643359-EA2200BB-0D1D-447B-989A-644C8BB8CAFAQ33662916-5D520906-1F29-4DF1-B1BC-2912F905B8BBQ33747235-57651559-2FFD-4F97-ABBC-8A56BDE15E4DQ33952766-C342DF73-821E-4726-991F-DFA4DA45585DQ34611232-1A6BB7AB-0A9E-4CE9-8A43-FFEB30B6AC0FQ35624990-95AD31DA-B920-49C3-AE54-545C99EDAB92Q35743755-1322F26B-9DC4-4FA5-B409-5E51E3C5658CQ35757411-9C5214F8-47D2-408C-AD95-4A4A8787B102Q36630103-9770C198-220D-435D-9B2A-1046FE7AD9A4Q36828315-9C38786C-026C-461F-80EF-ED600881748DQ37372833-CF933684-63A4-47CA-9B02-508CB0EF3D03Q37379570-CF52A3B9-88D8-4E1E-9BDF-2393FF135B19Q37810271-1EDF0009-734C-4258-A37B-634EA73D44D2Q41489289-262B4E7D-0AA3-47C1-9B62-CC2746E803E4Q42739970-568D6D01-DBE3-4722-8416-DA7C64F17495Q42857933-2143AA4A-784E-4FDA-B630-4563E40B8900Q43584086-6618C6F5-46CF-4546-BE95-A59C91DD0C17Q52177999-B12CE2CC-E4FA-4122-8E7B-FFA4BA6887C6Q52314065-69568679-E28A-4936-BD2C-B8756DCF5CF1Q53060966-2CE72E00-5D82-4408-935E-C1534CDFE80E
P2860
Down syndrome and leukemia: unusual clinical aspects and unexpected methotrexate sensitivity.
description
1987 nî lūn-bûn
@nan
1987 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Down syndrome and leukemia: un ...... cted methotrexate sensitivity.
@ast
Down syndrome and leukemia: un ...... cted methotrexate sensitivity.
@en
type
label
Down syndrome and leukemia: un ...... cted methotrexate sensitivity.
@ast
Down syndrome and leukemia: un ...... cted methotrexate sensitivity.
@en
prefLabel
Down syndrome and leukemia: un ...... cted methotrexate sensitivity.
@ast
Down syndrome and leukemia: un ...... cted methotrexate sensitivity.
@en
P356
P1476
Down syndrome and leukemia: un ...... cted methotrexate sensitivity.
@en
P2093
P2888
P304
P356
10.1007/BF00444952
P577
1987-07-01T00:00:00Z
P6179
1030786480